Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Rituximab
MabThera
Not routinely available
SMC (SMC2165)
11/03/2019
Indication
In combination with glucocorticoids, for the treatment of adult patients with severe, active granulomatosis with polyangiitis (Wegener’s) (GPA) and microscopic polyangiitis (MPA).
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
100mg, 500mg solution for infusion
Comments
None
Link to Advice
Advice Published
11/03/2019
SMC Submission Type
Non submission
SMC Status
Not recommended